News

The Case for a Paradigm Shift in the Management of Hyperkalemia for CKD Patients

Guest Contributor Jessica Coleman, MD As a practicing nephrologist, I often see chronic kidney disease (CKD) patients with hyperkalemia—defined as a serum potassium level >5.0 mEq/L. That is not surprising given that the prevalence of hyperkalemia among patients with CKD is considerably higher than in the general population—40% to 50% versus 2% to 3%.1 These patients tend to be elderly, ... Read More »

November 2017: Abstract Roundup

Chronic Kidney Disease Direct-Acting Antiviral HCV  Treatment Safe and Effective in CKD Patients Clinical Journal of the American Society of Nephrology. doi:10.2215/CJN.02510317 Patients with chronic kidney disease (CKD) commonly present with hepatitis C virus (HCV) infection, a complication that can lead to accelerated progression to end-stage renal disease. Sofosbuvir, a direct-acting antiviral agent, is known to be effective and safe ... Read More »

November 2017: News Briefs

Cricket Names Danny Shapiro CBO Danny Shapiro has been named chief business officer of Cricket Health, a developer of technology-enabled care solutions for patients with chronic kidney disease and end-stage renal disease. Mr. Shapiro was most recently chief operating officer of Home Care Assistance and prior to that held the position of vice president at DaVita Kidney Care. In a ... Read More »

Food Insecurity Associated with Risk for Progression of CKD

The US Department of Agriculture defines food security as a person’s perceived ability to obtain nutritious and healthy food with essential nutrients, fruits, and vegetables, and limited amounts of saturated fats, sugar, and salt for an active and healthy life. Estimates of households in America classified as food insecure in 2014 were 14.3%; food insecurity was characterized as lack of ... Read More »

KDIGO CKD Referral Guidelines: Feasibility of Adherence

Early referral of patients with chronic kidney disease (CKD) to specialist nephrology care is associated with benefits that include reduced mortality at 3 months to 5 years of follow-up, reduced costs, reduced length of stay among hospitalized patients, increased quality of life, and earlier placement of preferred dialysis access. One objective of the US Office of Disease Prevention and Health ... Read More »

CRRTnet: Observational Study of Prescription and Delivery of Continuous Renal Replacement Therapy

More than half of admission to the intensive care unit (ICU) are complicated by acute kidney injury (AKI), and approximately 5% to 6% of patients admitted to the ICU require renal replacement therapy (RRT). Among patients with hemodynamic instability, continuous RRT (CRRT) is the dialysis modality of choice in high-income nations. According to Michael Heung, MD, MS, and colleagues, there ... Read More »

Early Frequent Nephrology Care Reduces Cardiovascular Risk Factors Postdialysis

Compared with age-matched controls, patients with chronic kidney disease (CKD) face a 5- to 10-fold higher risk for cardiovascular disease, including coronary artery disease, stroke, and heart failure. Cardiovascular events are the leading cause of death in patients with CKD. Interventions aimed at controlling traditional risk factors for cardiovascular disease (hypertension, diabetes, and dyslipidemia) were not associated with improvement in ... Read More »

October 2017: Abstract Roundup

Acute Kidney Injury 30-Day Outcomes Poor Following Discharge from the ED with AKI Clinical Journal of the American Nephrology Society. 2017, doi: 10.2215/CJN.10431016 Rey R. Acedillo, MD, and colleagues conducted a population-based retrospective cohort study designed to examine the characteristics and outcomes of patients discharged home from an emergency department (ED) with acute kidney injury (AKI). The cohort included 6346 ... Read More »

October 2017: News Briefs

LUTONIX® 035 DCB Granted FDA Approval In late August, the US FDA granted premarket approval to the LUTONIX® 035 drug coated balloon (DCB) PTA catheter. The LUTONIX 035 is now available in the United States. In a press release from C.R. Bard, Inc., the manufacturer of the catheter, Timothy M. Ring, chairman and chief executive officer, said, “This approval offers ... Read More »

Review and Meta-Analysis to Assess Renal Outcomes with Intensive Blood Pressure Control

Patients with chronic kidney disease face increased risk of diabetes, cardiovascular morbidity, and mortality; nondiabetic CKD accounts for most of the incidence worldwide. Hypertension is strongly associated with the development of progression of nondiabetic CKD, and control of blood pressure can decrease the risk of decline in renal function and cardiovascular mortality. However, according to Wan-Chuan Tsai, MD, and colleagues ... Read More »